James F. Meschia|Peter Merrill|Elsayed Z. Soliman|Virginia J. Howard|Kevin Barrett|Neil A. Zakai|Dawn Kleindorfer|Monika M. Safford|George Howard
Racial Disparities in Awareness and Treatment of Atrial Fibrillation
University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University|University of Alabama at Birmingham|University of Vermont|Mayo Clinic in Arizona|University of Cincinnati|Wake Forest University
background purpose warfarin reduces stroke risk approximately 60 patients atrial fibrillation af differences awareness treatment af may contribute racial geographic disparities stroke mortality objective examine predictors awareness diagnosis af treatment warfarin methods asons g eographic nd r acial ifferences troke regards national populationbased longitudinal study 30 239 blacks whites 45 years old oversampling blacks southeastern stroke belt states participants enrolled january 2003 october 2007 data collected using telephone interview inhome evaluation selfadministered questionnaires main variable awareness af defined positive answer doctor health professional ever told atrial fibrillation whether evidence treatment basis inhome medications inventory results baseline electrocardiograms 432 individuals 88 black 344 white af 88 360 409 least 1 additional chads 2 stroke risk factor 60 258 432 aware af odds blacks aware af one third whites or032 95 ci 020 052 among aware odds blacks treated warfarin one fourth great whites or028 013 060 conclusion blacks less likely whites aware af treated warfarin potential reasons racial disparity warfarin treatment warrant investigation